Dinner Short Course: Organized by Cambridge Healthtech Institute
Structure- and Dynamics-Based Design Strategies
Tuesday, ...
Upcoming SlideShare
Loading in...5
×

Course: Structure-and Dynamics-Based Design Strategies

44

Published on

Tuesday, May 20, 2014 | 6:00-9:00 pm
Westin Boston Waterfront, Boston, MA

This course will reveal design strategies that led to drugs currently in the clinic and on the market. An emphasis will be made on the exploitation of the bioactive ligand conformations using combinations of NMR, X-ray, calculations and SAR. Rational design and the implications of other properties will be addressed which include atropisomer chirality, drug self-aggregation and ADMET. This course will be held prior to the start of the 14th annual “Structure-Based Drug Design (SBDD)” conference being held on May 21-22.

Published in: Science
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
44
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
1
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Course: Structure-and Dynamics-Based Design Strategies

  1. 1. Dinner Short Course: Organized by Cambridge Healthtech Institute Structure- and Dynamics-Based Design Strategies Tuesday, May 20, 2014 | 6:00-9:00 pm Westin Boston Waterfront, Boston, MA This course will reveal design strategies that led to drugs currently in the clinic and on the market. An emphasis will be made on the exploitation of the bioactive ligand conformations using combinations of NMR, X-ray, calculations and SAR. Rational design and the implications of other properties will be addressed which include atropisomer chirality, drug self-aggregation and ADMET. This course will be held prior to the start of the 14th annual “Structure-Based Drug Design (SBDD)” conference being held on May 21-22. Instructors: Steven LaPlante, Ph.D., Founder & CEO, NMX Research & Solutions; Adjunct Professor, Institut National de la Recherche Scientifique (INRS) Chris Williams, Ph.D., Principal Scientist, Chemical Computing Group Detailed Agenda: 6:00 Dinner Served 6:15 Strategies for Drug Design Starting from Peptides, HTS Hits and Small-Molecule Fragments Steven LaPlante, Ph.D., Founder & CEO, NMX Research & Solutions; Adjunct Professor, Institut National de la Recherche Scientifique (INRS) 7:15 Coffee Break 7:45 Designing Inhibitors with MOE Structure-Based Drug Design Tools Chris Williams, Ph.D., Principal Scientist, Chemical Computing Group 8:45 Q&A with Speakers 9:00 Close of Course. How to Register: Web: https://chidb.com/register/2014/sbd/reg.asp Call: 781-972-5400 Email: reg@healthtech.com www.healthtech.com/structure-based-drug-design

×